Renaissance Group LLC Biogen Inc. Transaction History

Renaissance Group LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $521,662 - $785,231	-2,208 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $95,317 - $110,055	-360 Reduced 14.02%	2,208 $626,000
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $63,371 - $83,924	245 Added 10.55%	2,568 $687,000
Q1 2020 May 06, 2020	SELL	$268.85 - $341.04 $126,359 - $160,288	-470 Reduced 16.83%	2,323 $735,000
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $11,443 - $15,811	52 Added 1.9%	2,793 $829,000
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $18,047 - $20,242	-83 Reduced 2.94%	2,741 $638,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $17.3 Million - $19.1 Million	-79,004 Reduced 96.55%	2,824 $660,000
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $1.53 Million - $2.4 Million	-7,078 Reduced 7.96%	81,828 $19.3 Million
Q4 2018 Feb 04, 2019	SELL	$278.5 - $352.75 $2.35 Million - $2.98 Million	-8,446 Reduced 8.68%	88,906 $26.8 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $2.4 Million - $3.14 Million	-8,193 Reduced 7.76%	97,352 $34.4 Million
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $928,617 - $1.11 Million	-3,606 Reduced 3.3%	105,545 $30.6 Million
Q1 2018 Apr 30, 2018	SELL	$260.13 - $367.91 $809,004 - $1.14 Million	-3,110 Reduced 2.77%	109,151 $29.9 Million
Q4 2017 Feb 06, 2018	SELL	$307.64 - $344.58 $2.01 Million - $2.25 Million	-6,530 Reduced 5.5%	112,261 $35.8 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $33.4 Million - $39.2 Million	118,791	118,791 $37.2 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Group LLC with notifications on news.